Article
A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up.
Diabetes research and clinical practice - 1 Jul 2017
Katanic Dragan, Vorgučin Ivana, Hattersley Andrew, Ellard Sian, Houghton Jayne A L, Obreht Dragana, Knežević Pogančev Marija, Vlaški Jovan, Pavkov Danijela
Abstract excerpt
Neonatal diabetes mellitus is a rare monogenic disease with incidence of 1/90,000 newborns. A case of two months aged male infant with life threatening diabetic ketoacidosis is presented with novel ABCC8 gene mutation (p.F577L), successful transition from insulin to sulfonylurea and follow-up of three years.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.